Abstract:Recently, it has been reported that testosterone membrane signaling regulates actin reorganization and induces pro-apoptotic responses in colon tumor cells. In the present study the membrane androgen receptors (mARs)-induced activation of Rac1 GTPase and the involvement of PI3K/Rac1 signaling in controlling the apoptotic responses in testosterone treated Caco2 colon cancer cells has been analyzed. In line with previous findings, activation of mAR by testosterone conjugates triggered early and transient actin r… Show more
“…In line with the reports in prostate cancer cells, in the breast cancer cell lines T47D and MDA-MB-231 the testosterone-induced apoptosis was also shown to be mediated by Rho/actin signaling [Pelekanou et al, 2010]. Finally, androgen stimulated actin cytoskeleton reorganization in Caco2 and HCT116 colon tumor cells, controlled by FAK/PI3K/mTOR/PAK1 [Gu et al, 2013] or PI3K/ Rac1 [Alkahtani, 2013] signaling, was also involved in the apoptotic responses [Gu et al, 2009;Alkahtani, 2013], since the drug cytochalasin B or the PI3K inhibitor wortmannin effectively inhibited pro-apoptotic signaling.…”
Section: Glucocorticoid Actions To Actin Reorganization Actin Signalsupporting
confidence: 82%
“…As discussed above, recent observations showed that actin reorganization initiated by steroids hormones, including glucocorticoids and androgens is controlling various cellular functions such as secretion, apoptotic responses and migratory potential in membrane hormone receptor‐stimulated human cancer cells [Charalampopoulos et al, ; Fu and Simoncini, ; Mayanagi et al, ; Papadopoulou et al, ; Gu et al, ; Fu et al, ; Pelekanou et al, ; Alkahtani, ]. These studies clearly establish a pivotal role of actin signaling linking membrane‐initiated, steroid hormone actions and regulation of cellular response mechanisms in different cancer cell types.…”
Early actin cytoskeleton reorganization is an important regulatory step of membrane-initiated, non-genomic steroid hormone actions. Specific intracellular signaling cascades control the rapid alterations of actin polymerization in a variety of cell models. Moreover, actin remodeling is a decisive component in the signaling of hormone-induced early and late cellular responses. This article briefly summarizes the current knowledge on the steroid hormone-induced early actin cytoskeleton rearrangements. It focuses on the current progress to characterize the glucocorticoid-and androgen-initiated, tissue-specific actin signaling pathways and discusses the plethora of cellular responses that are regulated by the early actin redistribution. It also provides insights into the potential clinical significance of actin dynamics and actin-specific molecular signaling for nongenomic steroid hormone actions on tumor cells. V C 2014 Wiley Periodicals, Inc.
“…In line with the reports in prostate cancer cells, in the breast cancer cell lines T47D and MDA-MB-231 the testosterone-induced apoptosis was also shown to be mediated by Rho/actin signaling [Pelekanou et al, 2010]. Finally, androgen stimulated actin cytoskeleton reorganization in Caco2 and HCT116 colon tumor cells, controlled by FAK/PI3K/mTOR/PAK1 [Gu et al, 2013] or PI3K/ Rac1 [Alkahtani, 2013] signaling, was also involved in the apoptotic responses [Gu et al, 2009;Alkahtani, 2013], since the drug cytochalasin B or the PI3K inhibitor wortmannin effectively inhibited pro-apoptotic signaling.…”
Section: Glucocorticoid Actions To Actin Reorganization Actin Signalsupporting
confidence: 82%
“…As discussed above, recent observations showed that actin reorganization initiated by steroids hormones, including glucocorticoids and androgens is controlling various cellular functions such as secretion, apoptotic responses and migratory potential in membrane hormone receptor‐stimulated human cancer cells [Charalampopoulos et al, ; Fu and Simoncini, ; Mayanagi et al, ; Papadopoulou et al, ; Gu et al, ; Fu et al, ; Pelekanou et al, ; Alkahtani, ]. These studies clearly establish a pivotal role of actin signaling linking membrane‐initiated, steroid hormone actions and regulation of cellular response mechanisms in different cancer cell types.…”
Early actin cytoskeleton reorganization is an important regulatory step of membrane-initiated, non-genomic steroid hormone actions. Specific intracellular signaling cascades control the rapid alterations of actin polymerization in a variety of cell models. Moreover, actin remodeling is a decisive component in the signaling of hormone-induced early and late cellular responses. This article briefly summarizes the current knowledge on the steroid hormone-induced early actin cytoskeleton rearrangements. It focuses on the current progress to characterize the glucocorticoid-and androgen-initiated, tissue-specific actin signaling pathways and discusses the plethora of cellular responses that are regulated by the early actin redistribution. It also provides insights into the potential clinical significance of actin dynamics and actin-specific molecular signaling for nongenomic steroid hormone actions on tumor cells. V C 2014 Wiley Periodicals, Inc.
“…However, the effect of androgens in CRC is unclear. In vitro T induced apoptosis in CRC cell lines ( 315 , 368 ), whereas DHEA enhances survival ( 315 ). In contrast, Tutton and Barkla ( 369 ) found that in vivo administration of T accelerated cell proliferation in the small intestine and induced colon cancer in rats, with CRC growth reduced after castration.…”
Section: Dysregulation Of Steroid Sulfation and Desulfationmentioning
Steroid sulfation and desulfation are fundamental pathways vital for a functional vertebrate endocrine system. After biosynthesis, hydrophobic steroids are sulfated to expedite circulatory transit. Target cells express transmembrane organic anion-transporting polypeptides that facilitate cellular uptake of sulfated steroids. Once intracellular, sulfatases hydrolyze these steroid sulfate esters to their unconjugated, and usually active, forms. Because most steroids can be sulfated, including cholesterol, pregnenolone, dehydroepiandrosterone, and estrone, understanding the function, tissue distribution, and regulation of sulfation and desulfation processes provides significant insights into normal endocrine function. Not surprisingly, dysregulation of these pathways is associated with numerous pathologies, including steroid-dependent cancers, polycystic ovary syndrome, and X-linked ichthyosis. Here we provide a comprehensive examination of our current knowledge of endocrine-related sulfation and desulfation pathways. We describe the interplay between sulfatases and sulfotransferases, showing how their expression and regulation influences steroid action. Furthermore, we address the role that organic anion-transporting polypeptides play in regulating intracellular steroid concentrations and how their expression patterns influence many pathologies, especially cancer. Finally, the recent advances in pharmacologically targeting steroidogenic pathways will be examined.
“…The concentration of sex steroids is one of the most important intrinsic factors that differ between both sexes 3 ; these molecules have important roles in the gut: Estrogens influence epithelial membrane permeability, serotonin production, expression of tight junctions, inflammation, and microbiome composition 4 ; Androgens are poorly understood; however, in a mouse model alters the proliferation of enterocytes and increases the size of crypts 5 . Further in vitro studies with colon cancer cell lines such as DLD-1, HCT-116, SW480, and CaCO2 have shown that estradiol reduces the viability of these cells, and testosterone (T4) and dihydrotestosterone (DHT) increase the apoptosis in CaCO2 and HCT116 [6][7][8][9][10][11][12][13][14][15] .…”
Background: Sexual dimorphism (SD) is the difference in morphology and physiology between sexes of the same species; in diseases, SD can reflect the susceptibility associated with gender in humans. In colorectal cancer, men have a higher incidence than women, independently between ethnicity or geographical location, suggesting that sex steroids are involved in the development of colorectal cancer.
Methods: We determined sex, as a risk factor for colorectal cancer from the GLOBOCAN database; Then, we used induction of colorectal tumors by azoxymethane and dextran sulfate of sodium treatment as the experimental strategy in males and females mice; also we gonadectomized independent males and females animals. Finally, we determined in vitro proliferation of a human cell line HCT116 exposed to estradiol, testosterone or dihytrotestosterone.
Results: Sex as a risk factor for colorectal cancer showed clear and statistically significant susceptibility of men in Mexico and worldwide. In the murine model of colorectal tumors, males developed more and larger tumors than females. Further analysis showed that ovariectomized females develop more tumors in number, but all about the same size. Meanwhile gonadectomized males had fewer tumors in number and smaller in size. Surprisingly, only estradiol showed an effect in vitro on the proliferation index on human cell lines of colorectal cancer.
Conclusions: Men showed enhanced susceptibility to develop colorectal cáncer tan females; in the animal model, male mice presented augmented development of colorectal tumors, which was reverted in gonadectomized male mice, female mice increased the number of tumor, the above suggests that androgens have a crucial role in explaining sexual dimorphism in the incidence of colorectal cancer. Estradiol diminished the in vitro proliferation of HCT-116 colon cancer cell line, opposite, there was no change of in vitro proliferation on cells exposed to testosterone or dihydrotestosterone, therefore, the effect in vitro could be by their interaction with other cells or systems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.